Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Nucleic Acids

TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Nucleic Acids, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Nucleic Acids technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Nucleic Acids

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions
BECKMAN COULTER7
WITHERS & ROGERS7
JAMES POOLE6
SANOFI6
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB5
HOFFMANN EITLE5
STRAWMAN5
COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB5
BOULT WADE TENNANT4
BIONTECH4

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

CompanyTotal Oppositions
MODERNATX34
MODERNA THERAPEUTICS12
BECTON DICKINSON INFUSION THERAPY SYSTEMS8
ILLUMINA CAMBRIDGE8
GENEOHM SCIENCES8
THE GENERAL HOSPITAL7
SILENCE THERAPEUTICS7
DANA FARBER CANCER INSTITUTE6
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA6
TRANSLATE BIO6

Top active law firms filing patent oppositions New

Explore the top law firms that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions Filed
BOULT WADE TENNANT12
CARPMAELS & RANSFORD11
HOFFMANN EITLE9
WICHMANN6
POTTER CLARKSON5
COHAUSZ & FLORACK5
MAIWALD5
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB5
WILK4
PATENT BOUTIQUE3

Latest patents opposed in the Nucleic Acids industry

Patent challenges are becoming increasingly common in the Nucleic Acids industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Nucleic Acids industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Nucleic Acids industry

EP3227447Guide Rna With Chemical ModificationsAGILENTJan 24, 2025KRAUS & LEDERER PARTGMBB
EP3227447Guide Rna With Chemical ModificationsAGILENTJan 22, 2025DORRIES
EP3227447Guide Rna With Chemical ModificationsAGILENTJan 14, 2025WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB
EP4104687Compositions And Methods For Synthesizing 5 -Capped RnasTRILINK BIOTECHNOLOGIESOct 30, 2024COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3517134Adeno-Associated Virus (Aav) Serotype 8 Sequences, Vectors Containing Same And Uses ThereforTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAOct 16, 2024STRAWMAN
EP3227447Guide Rna With Chemical ModificationsAGILENTSep 23, 2024JAMES POOLE
EP3906789Compositions And Methods For Synthesizing 5 -Capped RnasTRILINK BIOTECHNOLOGIESAug 22, 2024COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3954225Compositions And Methods For Synthesizing 5'-Capped RnasTRILINK BIOTECHNOLOGIESAug 22, 2024COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3870594Process For The Purification Of OligonucleotidesF HOFFMANN LA ROCHEMay 2, 2024CYTIVA SWEDEN
EP4140491Compositions And Methods For Synthesizing 5'-Capped RnasTRILINK BIOTECHNOLOGIESApr 12, 2024COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB

Top patents facing oppositions in Nucleic Acids industry

To stay ahead in the competitive Nucleic Acids industry, companies are constantly innovating. Here are the top patents facing oppositions in the Nucleic Acids industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX10
EP3682905Dec 1, 2021Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNATX10
EP3590949May 18, 2022Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNATX9
EP3227447Apr 24, 2024Guide Rna With Chemical ModificationsAGILENT4
EP3214091Oct 3, 2018Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA4
EP2258847Jul 1, 2020Futher Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICS3
EP1857547Dec 2, 2020Further Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICS3
EP2279254Jul 5, 2017Novel Lipid Formulations For Nucleic Acid DeliveryPROTIVA BIOTHERAPEUTICS2
EP2439284May 8, 2019Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting TreatmentsTHE GENERAL HOSPITAL2
EP2325644Jul 29, 2020Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type XiiBECTON DICKINSON INFUSION THERAPY SYSTEMS2